ArticleBritish journal of cancer2024

GFPT2: A novel biomarker in mesothelioma for diagnosis and prognosis and its molecular mechanism in malignant progression.

Jia Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.